WFM
BIIB icon

Wilmington Funds Management’s Biogen BIIB Stock Holding History

Wilmington Funds Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$2.33M Buy
7,400
+654
+10% +$197K 0.24% 120
2014
Q1 		$2.06M Sell
6,746
-1,600
-19% -$508K 0.22% 125
2013
Q4 		$2.33M Sell
8,346
-1,530
-15% -$396K 0.23% 125
2013
Q3 		$2.38M Sell
9,876
-900
-8% -$201K 0.23% 145
2013
Q2 		$2.32M Buy
+10,776
New +$2.3M 0.22% 144

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wilmington Funds Management's BIIB Position: Q2 2014 in Review

Wilmington Funds Management increased its Biogen (BIIB) stake by 9.7% in Q2 2014, buying an estimated $197K and bringing the position to 7,400 shares worth $2.33M. The position accounts for 0.24% of the portfolio, ranked #120.

Wilmington Funds Management first reported a position in BIIB in Q2 2013 and has held it in 5 quarters since. The position peaked at $2.38M in Q3 2013. 782 funds tracked by Wall St. Rank hold BIIB as of Q2 2014.

  • Wilmington Funds Management held 7,400 shares of Biogen worth $2.33M as of Q2 2014.
  • Wilmington Funds Management bought 654 Biogen shares in Q2 2014, an estimated $197K.
  • Biogen made up 0.24% of Wilmington Funds Management's portfolio in Q2 2014, its #120 holding.
  • Wilmington Funds Management first reported a position in Biogen in Q2 2013 and has held it in 5 quarters since.
  • Wilmington Funds Management's Biogen position peaked at $2.38M in Q3 2013.
  • 782 funds tracked by Wall St. Rank held Biogen as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.